Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 HollisterStier Signs Contract with MGI Pharma | Contract Pharma
Breaking News, Collaborations & Alliances

HollisterStier Signs Contract with MGI Pharma

HollisterStier Contract Manufacturing signed a construction, validation and supply agreement with MGI Pharma, Inc. Spokane, WA-based HollisterStier is building a new compounding suite for MGI Pharma to accommodate the manufacturing process for ZYC101a, an investigational therapeutic designed to augment the body’s defensive response to human papillomavirus (HPV).

Preliminary engineering plans for the suite are currently underway and the company expects to have construction complete in May of this year. Validation of the new 1,000-sq.-ft. compounding suite will take the remainder of the year.

“HollisterStier is pleased to partner with MGI Pharma on this project. Clearly this is another example of how HollisterStier’s technical expertise can readily accommodate our contract customers in an extremely timely manner,” said Anthony Bonanzino, president and chief executive officer.

William Vincek, senior vice president, technical operations of MGI Pharma, said, “HollisterStier Contract Manufacturing is an excellent partner for the development and management of complex manufacturing processes. With their technical knowledge supporting our unique processes and scale, we believe HollisterStier will be able to meet the needs of our current clinical plans and of our commercial launch projections.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters